Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1No longer available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Brain Neoplasms 6Breast Neoplasms 4Recurrence 2Oligodendroglioma 2Meningeal Carcinomatosis 2Glioblastoma 2Astrocytoma 2Triple Negative Breast Neoplasms 1Meningeal Neoplasms 1Melanoma 1Lung Neoplasms 1Glioma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

paclitaxel-Angiopep-2 conjugate 2osimertinib 2omburtamab I-131 2AZD3759 2eribulin 1XL647 1WP 744 1Methotrexate 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Meningeal Carcinomatosis × paclitaxel-Angiopep-2 conjugate × Clear all
NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown
150 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT02755987 2016-06-07

Expanded Access to ANG1005 for Individual Patients

Angiochem Inc

No longer available
CNS

Astrocytoma, Oligodendroglioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡